Biopharmaceutical R&D
Nanotechnology-based Drug Delivery
Potential, progress and the way forward…
The concept of nanotechnology was first described by Nobel laureate Richard Feynman in a popular lecture he gave entitled Theres Plenty of Room at the Bottom on December
Want more success?
An interview with Robert 'Bob' Lefkowitz
Bob was depressed As a high achiever he wasnt used to failure But failing he was And badly The year was and try as he might he could not progress his research During a pep talk with a senior scientist the older man asked Bob What percentage of an average scientists experiments do you think are successful Bob shrugged
A New Strategy to Predict Neurovirulence Risk Associated with Covid-19 Vaccines
For seamless adoption
Vaccines derived from live attenuated viruses are required by law to be subject to tests for residual neurovirulence before use This applies to vaccines which comprise whole neurotropic viruses vaccines which have a neurotropic component or those which have been passaged in neural tissue
How to Study Drug Transport at Biological Interfaces
Drugs as small or mediumsized molecules nanometer in diameter typically possess both lipophilic and hydrophilic properties For a drug molecule to reach its intracellular target it usually needs to cross several barriers including mucus gel layer intestinal epithelial cells capillary endothelium and finally membrane of target cells
Pharmaceutical Grade Quats and Recombinant Insulin
A global and leading supplier
Novo Nordisk Pharmatech AS is a global and leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries
